Hepatobiliary complications in patients with sickle cell disease: A 30-year review of 1009 patients
Maya Deeb(University Health Network), Gideon M. Hirschfield(University Health Network), Kristel Leung(University of Ottawa), Jordan J. Feld(University Health Network), Kevin H.M. Kuo(University Health Network), Richard Ward(University of Tennessee Health Science Center)
Cited by 6
Related Papers
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
|New England Journal of Medicine|2013|1.1k
Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
|New England Journal of Medicine|2014|907